Compare Autozone Inc (AZO) vs Bristol-Myers Squibb Co (BMY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Autozone Inc vs Bristol-Myers Squibb Co — how do they compare? Autozone Inc trades at $3,025.08 (market cap $49.67B), while Bristol-Myers Squibb Co trades at $63.41 (market cap $129.94B). The key difference: Bristol-Myers Squibb Co is far larger — about 2.6× Autozone Inc's market cap, and Bristol-Myers Squibb Co pays a 3.96% dividend while Autozone Inc pays none. Which is the better fit depends on your goals.
| AZO | BMY | |
|---|---|---|
Market Cap | $49.67B | $129.94B |
Sector | Consumer Cyclical | Health |
52-Week High | $4.35K | $65.89 |
52-Week Low | $2.92K | $42.60 |
Enterprise Value | $62.05B | $163.92B |
Dividend Yield | — | 3.96% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Autozone Inc
AutoZone is the premier seller of aftermarket automotive parts, tools, and accessories to do-it-yourself customers in the United States. The company derives an increasing proportion of its sales from domestic commercial customers, although its presence in its home market is still dominated by its do-it-yourself operation, which accounts for nearly 75% of sales in country. AutoZone also has a growing presence in Mexico and Brazil. AutoZone had 6,767 stores in the U.S. (6,051), Mexico (664), and Brazil (52) as of the end of fiscal 2021.
Read more on AZO →About Bristol-Myers Squibb Co
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs, which tend to support strong pricing power.
Read more on BMY →
